 BETHESDA, Md., May 12, 2021 PRNewswire -- Northwest Biotherapeutics OTCQB: NWBO NW Bio, a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, today announced that an application for certification of the manufacturing facility in Sawston, UK has been submitted to the Medicines and Healthcare Products Regulatory Agency MHRA. 